|
1
|
Zhang J, Gao Y, Yan J. Roles of Myokines and Muscle-Derived Extracellular Vesicles in Musculoskeletal Deterioration under Disuse Conditions. Metabolites 2024; 14:88. [PMID: 38392980 PMCID: PMC10891558 DOI: 10.3390/metabo14020088] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2023] [Revised: 01/10/2024] [Accepted: 01/17/2024] [Indexed: 02/25/2024] Open
Abstract
Prolonged inactivity and disuse conditions, such as those experienced during spaceflight and prolonged bedrest, are frequently accompanied by detrimental effects on the motor system, including skeletal muscle atrophy and bone loss, which greatly increase the risk of osteoporosis and fractures. Moreover, the decrease in glucose and lipid utilization in skeletal muscles, a consequence of muscle atrophy, also contributes to the development of metabolic syndrome. Clarifying the mechanisms involved in disuse-induced musculoskeletal deterioration is important, providing therapeutic targets and a scientific foundation for the treatment of musculoskeletal disorders under disuse conditions. Skeletal muscle, as a powerful endocrine organ, participates in the regulation of physiological and biochemical functions of local or distal tissues and organs, including itself, in endocrine, autocrine, or paracrine manners. As a motor organ adjacent to muscle, bone tissue exhibits a relative lag in degenerative changes compared to skeletal muscle under disuse conditions. Based on this phenomenon, roles and mechanisms involved in the communication between skeletal muscle and bone, especially from muscle to bone, under disuse conditions have attracted widespread attention. In this review, we summarize the roles and regulatory mechanisms of muscle-derived myokines and extracellular vesicles (EVs) in the occurrence of muscle atrophy and bone loss under disuse conditions, as well as discuss future perspectives based on existing research.
Collapse
Affiliation(s)
- Jie Zhang
- Institute of Special Medicine, Shanxi Medical University, Jinzhong 030619, China;
| | - Yunfang Gao
- Shaanxi Key Laboratory for Animal Conservation, College of Life Sciences, Northwest University, Xi’an 710069, China
| | - Jiangwei Yan
- Institute of Special Medicine, Shanxi Medical University, Jinzhong 030619, China;
| |
Collapse
|
|
2
|
Leger C, Quirié A, Méloux A, Fontanier E, Chaney R, Basset C, Lemaire S, Garnier P, Prigent-Tessier A. Impact of Exercise Intensity on Cerebral BDNF Levels: Role of FNDC5/Irisin. Int J Mol Sci 2024; 25:1213. [PMID: 38279218 PMCID: PMC10816613 DOI: 10.3390/ijms25021213] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2023] [Revised: 01/16/2024] [Accepted: 01/17/2024] [Indexed: 01/28/2024] Open
Abstract
The positive effects of physical exercise (EX) are well known to be mediated by cerebral BDNF (brain-derived neurotrophic factor), a neurotrophin involved in learning and memory, the expression of which could be induced by circulating irisin, a peptide derived from Fibronectin type III domain-containing protein 5 (FNDC5) produced by skeletal muscle contraction. While the influence of EX modalities on cerebral BDNF expression was characterized, their effect on muscle FNDC5/Irisin expression and circulating irisin levels remains to be explored. The present study involved Wistar rats divided into four experimental groups: sedentary (SED), low- (40% of maximal aerobic speed, MAS), intermediate- (50% of MAS) and high- (70% of MAS) intensities of treadmill EX (30 min/day, 7 days). Soleus (SOL) versus gastrocnemius (GAS) FNDC5 and hippocampal BDNF expressions were evaluated by Western blotting. Additionally, muscular FNDC5/Irisin localization and serum/hippocampal irisin levels were studied by immunofluorescence and ELISA, respectively. Our findings revealed that (1) serum irisin and hippocampal BDNF levels vary with EX intensity, showing a threshold intensity at 50% of MAS; (2) hippocampal BDNF levels positively correlate with serum irisin but not with hippocampal FNDC5/Irisin; and (3) GAS, in response to EX intensity, overexpresses FNDC5/Irisin in type II muscle fibers. Altogether, peripheral FNDC5/Irisin levels likely explain EX-dependent hippocampal BDNF expression.
Collapse
Affiliation(s)
- Clémence Leger
- Inserm Unité Mixte de Recherche 1093-Cognition, Action & Plasticité Sensorimotrice, Unité de Formation et de Recherche Sciences de Santé, Université de Bourgogne, F-21000 Dijon, France; (C.L.); (A.Q.); (A.M.); (E.F.); (R.C.); (C.B.); (P.G.)
| | - Aurore Quirié
- Inserm Unité Mixte de Recherche 1093-Cognition, Action & Plasticité Sensorimotrice, Unité de Formation et de Recherche Sciences de Santé, Université de Bourgogne, F-21000 Dijon, France; (C.L.); (A.Q.); (A.M.); (E.F.); (R.C.); (C.B.); (P.G.)
| | - Alexandre Méloux
- Inserm Unité Mixte de Recherche 1093-Cognition, Action & Plasticité Sensorimotrice, Unité de Formation et de Recherche Sciences de Santé, Université de Bourgogne, F-21000 Dijon, France; (C.L.); (A.Q.); (A.M.); (E.F.); (R.C.); (C.B.); (P.G.)
| | - Estelle Fontanier
- Inserm Unité Mixte de Recherche 1093-Cognition, Action & Plasticité Sensorimotrice, Unité de Formation et de Recherche Sciences de Santé, Université de Bourgogne, F-21000 Dijon, France; (C.L.); (A.Q.); (A.M.); (E.F.); (R.C.); (C.B.); (P.G.)
| | - Rémi Chaney
- Inserm Unité Mixte de Recherche 1093-Cognition, Action & Plasticité Sensorimotrice, Unité de Formation et de Recherche Sciences de Santé, Université de Bourgogne, F-21000 Dijon, France; (C.L.); (A.Q.); (A.M.); (E.F.); (R.C.); (C.B.); (P.G.)
| | - Christelle Basset
- Inserm Unité Mixte de Recherche 1093-Cognition, Action & Plasticité Sensorimotrice, Unité de Formation et de Recherche Sciences de Santé, Université de Bourgogne, F-21000 Dijon, France; (C.L.); (A.Q.); (A.M.); (E.F.); (R.C.); (C.B.); (P.G.)
| | - Stéphanie Lemaire
- Centre Hospitalier Universitaire Dijon, Service de Biochimie Spécialisée, F-21000 Dijon, France;
| | - Philippe Garnier
- Inserm Unité Mixte de Recherche 1093-Cognition, Action & Plasticité Sensorimotrice, Unité de Formation et de Recherche Sciences de Santé, Université de Bourgogne, F-21000 Dijon, France; (C.L.); (A.Q.); (A.M.); (E.F.); (R.C.); (C.B.); (P.G.)
- Département Génie Biologique, Institut Universitaire et Technologique, F-21000 Dijon, France
| | - Anne Prigent-Tessier
- Inserm Unité Mixte de Recherche 1093-Cognition, Action & Plasticité Sensorimotrice, Unité de Formation et de Recherche Sciences de Santé, Université de Bourgogne, F-21000 Dijon, France; (C.L.); (A.Q.); (A.M.); (E.F.); (R.C.); (C.B.); (P.G.)
| |
Collapse
|